Emergency and Critical Care

Lead poisoning in children: screening, diagnosis, and management

Clinical Overview and When to Suspect

Lead poisoning remains a significant yet preventable cause of neurodevelopmental harm in children, with no safe blood lead level (BLL) established.

CDC reference value: ≥3.5 µg/dL (updated 2021, based on 97.5th percentile of NHANES data in children 1–5 years)

Lead exposure causes irreversible neurocognitive damage at low levels — IQ loss, behavioral problems, learning disabilities

Most children with elevated BLL are ASYMPTOMATIC → screening is essential

Symptomatic lead poisoning (BLL typically ≥45–70 µg/dL): abdominal pain, constipation, irritability, anorexia, fatigue

Lead encephalopathy (BLL often ≥70–100 µg/dL): vomiting, ataxia, altered mental status, seizures, cerebral edema → MEDICAL EMERGENCY

Board pearl: The most common presentation of lead poisoning on boards is an asymptomatic toddler found to have elevated BLL on routine screening — the key is knowing who, when, and how to screen

Age group at highest risk: 1–3 years (hand-to-mouth behavior + rapid brain development)

History — Risk Factor Identification

History is the primary tool for identifying children who need screening or who may have lead exposure.

Housing: pre-1978 homes (lead-based paint is #1 source in the US), recent renovation/remodeling of older homes, peeling/chipping paint

Geography: older housing stock areas, proximity to industrial sites, known lead-contaminated water systems

Occupation/hobbies of household members: battery recycling, construction, auto repair, stained glass, shooting ranges, pottery with lead glazes

Immigration/adoption: children from countries where lead is prevalent in fuels, traditional remedies, or cookware

Traditional/folk remedies: azarcon, greta (Hispanic), surma/kohl (South Asian), pay-loo-ah (Hmong), litargirio

Imported spices, cosmetics, toys, jewelry, candy (especially from Mexico)

Pica behavior: eating paint chips, soil ingestion

Siblings or playmates with elevated BLL

Clinical tip: Medicaid enrollment mandates BLL screening at ages 12 and 24 months regardless of risk — this is a federal requirement

Physical Exam and Age-Specific Presentation

Physical exam is usually NORMAL in most children with lead poisoning — findings emerge only at higher levels.

General: pallor (lead-induced anemia), poor growth, developmental delay

Abdominal: diffuse tenderness, constipation (lead colic — typically BLL ≥45 µg/dL)

Neurologic: hyperactivity, inattention, clumsiness, ataxia, peripheral neuropathy (wrist/foot drop — rare in children, more common in adults)

Oral: "lead lines" (Burton lines) — blue-black discoloration along the gingival margin; rare in children, more common in adults with chronic exposure

Encephalopathy signs: lethargy, vomiting, papilledema, seizures, coma → BLL typically ≥70 µg/dL

Board pearl: In a toddler with developmental regression + microcytic anemia + pica + exposure history → think lead poisoning even if BLL result is pending

Age-specific: infants absorb ~50% of ingested lead (vs ~10% in adults) → higher vulnerability

Neonates: lead crosses the placenta → maternal lead exposure causes fetal toxicity, low birth weight, preterm birth

Diagnostic Workup — Blood Lead Level Testing

Blood lead level (BLL) is the gold standard for diagnosis.

→ <3.5 µg/dL → reference range (no action beyond routine rescreening)

→ 3.5–9 µg/dL → elevated; identify/eliminate source, nutritional counseling, rescreen in 1–3 months

→ 10–19 µg/dL → confirm in 1–4 weeks, environmental investigation, closer follow-up

→ 20–44 µg/dL → confirm within 1 week, environmental investigation, consider chelation if persistent

→ 45–69 µg/dL → confirm within 48 hours, chelation therapy indicated

→ ≥70 µg/dL → MEDICAL EMERGENCY → immediate chelation, hospitalize

Capillary (fingerstick) sample: used for screening — BUT prone to false elevations from skin contamination

Key distinction: ALL elevated capillary BLL results MUST be confirmed with a VENOUS sample before initiating management

Venous BLL: definitive test; interpret as follows:

Board pearl: The single most tested lead concept: capillary screen → must confirm with venous draw before acting

Ancillary Studies and Imaging

Beyond BLL, additional workup helps assess severity and complications.

CBC: microcytic, hypochromic anemia; basophilic stippling of RBCs (classic board finding — coarse stippling from inhibition of pyrimidine 5'-nucleotidase)

Iron studies: lead ↓ iron absorption and competes with iron; concurrent iron deficiency is common and worsens lead absorption

Free erythrocyte protoporphyrin (FEP) or zinc protoporphyrin (ZPP): ↑ when BLL >25–30 µg/dL; reflects inhibition of ferrochelatase; NOT sensitive at lower BLL

Reticulocyte count: may be ↑ (hemolytic component)

BMP: assess renal function (lead nephrotoxicity — proximal tubular damage, Fanconi-like syndrome)

Abdominal X-ray: radiopaque flecks in GI tract if recent ingestion of lead-containing material (paint chips, foreign body) → may guide whole bowel irrigation

Long bone X-rays: dense metaphyseal "lead lines" (↑ calcium deposition at growth plates) — NOT pathognomonic but classic board image

Board pearl: Lead lines on X-ray ≠ Burton lines on gums; both are classic but distinct findings

Management — Source Removal and Nutritional Optimization

The MOST IMPORTANT intervention at ANY BLL is identification and elimination of the lead source.

→ Adequate iron intake: iron deficiency ↑ GI lead absorption (they share the DMT-1 transporter); supplement if deficient

→ Adequate calcium: competes with lead for absorption

→ Regular meals: fasting ↑ lead absorption

→ Vitamin C: may modestly enhance iron absorption and reduce lead absorption

Environmental investigation: state/local health department referral for home inspection → professional abatement of lead-based paint hazards

Child must NOT return to contaminated environment until remediation is complete

Nutritional optimization:

Handwashing before meals, wet-mopping floors, running cold water before use (lead leaches from pipes into hot/stagnant water)

Clinical tip: Chelation without source removal is futile — lead rebounds from bone stores and re-exposure continues

Nutrition counseling and source elimination alone are sufficient for most children (BLL <45 µg/dL without symptoms)

Management — Chelation Therapy Indications and Agents

Chelation therapy is reserved for significantly elevated BLL or symptomatic poisoning.

→ Dose: 10 mg/kg every 8 hours × 5 days, then every 12 hours × 14 days

→ Outpatient if asymptomatic and reliable family

→ Monitor CBC, hepatic/renal function, BLL

→ Dual-agent parenteral therapy: dimercaprol (BAL) IM + CaNa₂EDTA IV

→ Critical: Start BAL FIRST (4 hours before EDTA) — giving EDTA alone can mobilize lead into the CNS and worsen encephalopathy

→ Dimercaprol dose: 75 mg/m² IM every 4 hours

→ CaNa₂EDTA dose: 1000–1500 mg/m²/day continuous IV infusion

BLL 45–69 µg/dL (symptomatic or asymptomatic): oral succimer (DMSA — dimercaptosuccinic acid)

BLL ≥70 µg/dL OR lead encephalopathy: HOSPITALIZE IMMEDIATELY

Board pearl: NEVER give CaNa₂EDTA alone in lead encephalopathy → always start with BAL first

D-penicillamine: rarely used; second-line oral option if succimer unavailable

Management — Emergency Stabilization of Lead Encephalopathy

Lead encephalopathy (BLL ≥70 µg/dL with seizures, AMS, cerebral edema) is a life-threatening emergency.

→ Elevate head of bed 30°

→ Avoid fluid overload — restrict to maintenance fluids; use isotonic solutions

→ Mannitol 0.25–1 g/kg IV or hypertonic saline if herniation signs

→ Avoid lumbar puncture (risk of herniation)

ABCs: secure airway; intubate if GCS ≤8 or status epilepticus

Seizure management: benzodiazepines first-line (lorazepam 0.1 mg/kg IV, max 4 mg)

↑ ICP management:

Begin dimercaprol (BAL) IM immediately → add CaNa₂EDTA IV 4 hours later

Whole bowel irrigation with polyethylene glycol if radiopaque material visible on abdominal X-ray → do NOT delay chelation for this

Admit to PICU; serial neurologic checks; repeat BLL every 24–48 hours

Board pearl: IV fluids must be restricted in lead encephalopathy because cerebral edema can worsen with volume overload

Even with aggressive treatment, mortality is ~5% and survivors may have permanent neurologic sequelae

Age-Specific Considerations — Infants and Toddlers

→ Lead crosses placenta → neonatal BLL reflects maternal exposure

→ Breastfeeding is generally safe even with mildly elevated maternal BLL (lead transfer into breast milk is low)

→ Screen if mother has elevated BLL or known exposure

→ Peak hand-to-mouth behavior → ingestion of paint chips, contaminated dust, soil

→ Rapid brain development → most vulnerable to neurotoxic effects

→ Iron deficiency peaks in this age → ↑ lead absorption via shared DMT-1 transporter

→ AAP/CDC: universal screening at 12 and 24 months for Medicaid-enrolled children; risk-based screening for others per state guidelines

Infants (0–12 months):

Toddlers (12–36 months): HIGHEST RISK age group

Clinical tip: A toddler in an old home undergoing renovation + pica + iron deficiency = classic board setup for lead poisoning

Children <6 years absorb proportionally more lead from the GI tract than older children or adults (~50% vs ~10%)

Age-Specific Considerations — School-Age and Adolescents

→ Lower screening rates; may present with learning difficulties, ADHD-like symptoms, declining school performance

→ Consider lead testing in children with unexplained behavioral/academic problems + risk factors

→ Lead affects executive function, attention, processing speed — effects are dose-dependent and IRREVERSIBLE

→ Occupational exposure: part-time jobs involving batteries, painting, auto body work, shooting ranges

→ Recreational: retained bullet/pellet fragments can slowly release lead → check BLL if penetrating injury with retained fragments

→ Substance use: some illicit drugs contaminated with lead

School-age children (6–12 years):

Adolescents:

Board pearl: There is NO threshold BLL below which cognitive effects are absent — even BLL <5 µg/dL is associated with ↓ IQ

Long-term follow-up: children with BLL ≥5 µg/dL should have developmental surveillance, educational assessment, and iron status monitoring

Lead stored in bone can be mobilized during pregnancy, puberty, or fracture healing → delayed toxicity years later

Complications — Acute and Chronic

Lead poisoning affects virtually every organ system; severity correlates with BLL and duration of exposure.

→ Acute: encephalopathy, seizures, cerebral edema, coma, death

→ Chronic: ↓ IQ (estimated 2–5 points per 10 µg/dL ↑ in BLL), ADHD, learning disabilities, behavioral problems, hearing loss

→ Mechanism: lead inhibits δ-aminolevulinic acid dehydratase (ALAD) and ferrochelatase → impaired heme synthesis

Neurologic (most concerning):

Hematologic: microcytic hypochromic anemia, basophilic stippling

Renal: proximal tubular dysfunction (glycosuria, aminoaciduria, phosphaturia — Fanconi-like), chronic nephropathy with prolonged exposure

GI: lead colic (colicky abdominal pain), constipation, anorexia

Skeletal: lead lines at metaphyses, ↓ bone growth

Reproductive (long-term): ↓ fertility, adverse pregnancy outcomes

Board pearl: Lead inhibits TWO enzymes in heme synthesis: ALAD (early) and ferrochelatase (late) → accumulation of ALA and protoporphyrin respectively

When to Escalate Care and Hospitalize

→ BLL ≥70 µg/dL — regardless of symptoms

→ Any signs of encephalopathy: seizures, persistent vomiting, altered consciousness, ataxia, papilledema

→ Symptomatic child with BLL ≥45 µg/dL who cannot be safely managed outpatient

→ Unsafe home environment (child cannot be removed from exposure source)

→ Unreliable follow-up for outpatient chelation

→ Concurrent severe iron deficiency requiring parenteral iron

→ Repeat chelation courses may be needed

Immediate hospitalization:

PICU admission for: encephalopathy, status epilepticus, signs of ↑ ICP

Urgent chelation indications: BLL ≥45 µg/dL

Consider hospitalization if:

Post-chelation: recheck BLL within 7–14 days → rebound is common (lead redistributes from bone)

Board pearl: A BLL rebound after chelation does NOT mean treatment failure — it reflects redistribution from bone stores and ongoing environmental exposure if source not eliminated

Key Differentials — Microcytic Anemia

Lead poisoning enters the differential for microcytic anemia, especially when co-occurring with iron deficiency.

→ Key distinction: Basophilic stippling is seen in lead poisoning, NOT in isolated iron deficiency

→ Lead: ↑ RDW, ↓ RBC count, basophilic stippling, ↑ FEP

Iron deficiency anemia: most common cause of microcytic anemia in toddlers; often coexists with lead poisoning (shared risk factors: low-income, poor nutrition)

Thalassemia trait: target cells, normal/↑ RBC count, normal RDW, elevated HbA₂ (β-thal trait)

Sideroblastic anemia: ringed sideroblasts on bone marrow; rare in children

Chronic disease anemia: typically normocytic; ↑ ferritin

Board pearl: Toddler with microcytic anemia + basophilic stippling + pica + developmental delay → think lead poisoning → check BLL

Remember: iron deficiency and lead poisoning frequently COEXIST → always check iron studies when BLL is elevated

Key Differentials — Encephalopathy and Abdominal Pain

→ Meningitis/encephalitis: fever, CSF pleocytosis; lead encephalopathy may have ↑ CSF protein but NO pleocytosis

→ Inborn errors of metabolism: hyperammonemia, organic acidurias

→ Toxic ingestions: iron, organophosphates, carbon monoxide

→ Intracranial mass, hydrocephalus

→ Reye syndrome (historical): ASA use + viral prodrome

→ Key distinction: LP is CONTRAINDICATED if lead encephalopathy is suspected due to risk of herniation from cerebral edema → obtain CT head first if etiology unclear

→ Intussusception: episodic colicky pain, "currant jelly" stool, target sign on ultrasound

→ Appendicitis: periumbilical → RLQ pain, fever

→ Constipation from other causes

→ Cyclical vomiting syndrome, abdominal migraine

Lead encephalopathy differential:

Lead colic differential:

Board pearl: An encephalopathic child with a history of pica living in a pre-1978 home = lead encephalopathy until proven otherwise → start chelation empirically while awaiting BLL

Screening — Who, When, and How

Screening strategy varies by risk profile and local/state guidelines.

→ All Medicaid-enrolled/eligible children at 12 months AND 24 months

→ Children 24–72 months with no prior test who are Medicaid-eligible → screen at first encounter

→ Use state or local guidelines; if none exist, screen if ANY risk factor present:

◦ Lives in or visits pre-1978 housing with deteriorating paint

◦ Sibling/playmate with elevated BLL

◦ Recent immigrant, refugee, or international adoptee

◦ Exposure to folk remedies, imported goods

◦ Parent/caregiver with occupational exposure

Universal screening (mandatory):

Risk-based screening (CDC/AAP recommendation for non-Medicaid populations):

Some states (e.g., NY, MA, IL) mandate universal screening regardless of insurance

Board pearl: Know that Medicaid children require screening at 12 AND 24 months — this is a commonly tested federal mandate

Method: capillary fingerstick is acceptable for screening → confirm elevated results with venous draw

Anticipatory Guidance and Prevention

→ Test homes built before 1978 for lead paint before occupancy or renovation

→ Professional abatement (not DIY) for lead paint — improper removal generates more lead dust

→ Run cold water ≥30 seconds before use for drinking/cooking (lead leaches from solder/pipes into warm stagnant water)

→ Use certified lead-free pottery, dishes, and cookware

→ Avoid folk remedies known to contain lead

→ Ensure adequate dietary iron and calcium

→ Adhere to screening schedules

→ Environmental investigation for any child with BLL ≥3.5 µg/dL

→ Chelation when indicated

→ Developmental follow-up, early intervention services, educational support

→ Repeat BLL monitoring until consistently <3.5 µg/dL

Primary prevention (before exposure):

Secondary prevention (early detection):

Tertiary prevention (minimize damage):

Clinical tip: Educate families that lead dust is invisible — wet mopping and handwashing are more effective than sweeping/vacuuming with standard vacuums

Family Counseling and Psychosocial Considerations

→ Many states have lead abatement assistance programs

→ Avoid blaming; focus on child safety and offering alternatives

Parental anxiety: many families feel guilt about lead exposure → normalize the concern, emphasize that treatment is effective and that the most critical step is source removal

Explain that neurodevelopmental effects are dose- and duration-dependent → early intervention improves outcomes even if effects are not fully reversible

Housing instability: families may resist reporting lead hazards for fear of eviction or cost → connect with local health department, legal aid, and housing resources

Immigrant/refugee families: culturally sensitive discussion about traditional remedies, cosmetics (kohl/surma), spices, and cookware containing lead

Developmental services: children with BLL ≥5 µg/dL should be referred for developmental assessment; early intervention (Part C <3 years, Part B ≥3 years) can mitigate cognitive effects

Board pearl: Lead poisoning disproportionately affects low-income and minority children → it is fundamentally an issue of environmental justice and health equity

High-Yield Associations and Rapid-Fire Facts

Lead inhibits ALAD and ferrochelatase → ↑ ALA in urine, ↑ FEP/ZPP

Basophilic stippling = aggregated ribosomes from inhibition of pyrimidine 5'-nucleotidase

Lead lines on X-ray = dense bands at metaphyses (↑ Ca²⁺ deposition), NOT the same as Burton lines (gingival)

Radiopaque flecks on abdominal X-ray → recent lead ingestion → whole bowel irrigation

Iron deficiency ↑ lead absorption (shared DMT-1 transporter)

Ca²⁺ competes with lead for GI absorption → adequate calcium is protective

BAL must precede CaNa₂EDTA to prevent ↑ CNS lead redistribution

Succimer (DMSA): only FDA-approved oral chelator for children

Lead is stored in bone (half-life ~25 years) → can remobilize during pregnancy, fractures, osteoporosis

No safe BLL → even <3.5 µg/dL associated with ↓ IQ

Board pearl: CDC reference value changed from 5 → 3.5 µg/dL in 2021 — boards may test updated threshold

Capillary screen → always confirm with venous sample

One-Line Recap

Lead poisoning is a silent, dose-dependent neurotoxin most dangerous to toddlers (1–3 years) in pre-1978 housing, diagnosed by venous BLL (reference ≥3.5 µg/dL), managed primarily through source elimination and nutritional optimization (iron, calcium), with chelation reserved for BLL ≥45 µg/dL (oral succimer) or ≥70 µg/dL/encephalopathy (dimercaprol first, then CaNa₂EDTA — never EDTA alone in encephalopathy), and prevented by universal Medicaid screening at 12 and 24 months, risk-based screening for others, and anticipatory guidance emphasizing that there is no safe blood lead level.

Board Question Stem Patterns

2-yr-old Medicaid patient, no prior BLL screening, lives in 1960s home → next step → capillary BLL screening (mandatory at 12 and 24 months)

Toddler with BLL 6 µg/dL on fingerstick → next step → confirm with venous BLL → if confirmed, environmental assessment + nutritional counseling + rescreen in 1–3 months

18-month-old, microcytic anemia, basophilic stippling, pica, lives in old home → diagnosis → lead poisoning → check venous BLL + iron studies

Child with venous BLL 50 µg/dL, asymptomatic → management → oral succimer (DMSA) + environmental investigation

3-yr-old with seizures, vomiting, BLL 85 µg/dL → management → hospitalize, BAL IM first → then CaNa₂EDTA IV 4 hours later; restrict fluids; manage seizures

Abdominal X-ray with radiopaque foreign material + elevated BLL → whole bowel irrigation + chelation

Post-chelation BLL rises from 25 → 40 µg/dL → explanation → redistribution from bone stores (expected rebound)

Board pearl: Vignette of encephalopathic child given CaNa₂EDTA alone → worsens → why? → EDTA alone mobilizes lead into CNS → must give BAL first

Previous Item

Next Item

eduo

visual

Emergency and Critical Care

eduovisual

Products

Exams

Company